{"id":28890,"date":"2017-08-10T15:48:24","date_gmt":"2017-08-10T13:48:24","guid":{"rendered":"http:\/\/www.invarena.cz\/?p=28890"},"modified":"2017-08-10T15:48:24","modified_gmt":"2017-08-10T13:48:24","slug":"cilena-lecba-dava-nadeji-zenam-s-rakovinou-prsu-v-poslednim-stadiu","status":"publish","type":"post","link":"https:\/\/www.invarena.cz\/?p=28890","title":{"rendered":"C\u00edlen\u00e1 l\u00e9\u010dba d\u00e1v\u00e1 nad\u011bji \u017een\u00e1m s rakovinou prsu v posledn\u00edm stadiu"},"content":{"rendered":"

Ka\u017edodenn\u00ed boj o \u010das. To je \u00fad\u011bl pacientek s metastatick\u00fdm karcinomem prsu. Tedy s nejpokro\u010dilej\u0161\u00edm stadiem rakoviny. V sou\u010dasn\u00e9 dob\u011b je v \u010cesk\u00e9 republice zhruba 3400 \u017een s touto krutou diagn\u00f3zou. Jejich pr\u016fm\u011brn\u00e1 doba p\u0159e\u017eit\u00ed je kolem \u010dty\u0159 let. Pro pacientky i pro l\u00e9ka\u0159e je proto kl\u00ed\u010dov\u00e9, co nejv\u00edce odd\u00e1lit dal\u0161\u00ed postup nemoci, a t\u00edm prodlou\u017eit \u017een\u00e1m \u017eivot. A\u017e tis\u00edcovce pacientek by mohla pomoci c\u00edlen\u00e1 l\u00e9\u010dba s pr\u016flomov\u00fdm \u00fa\u010dinkem.<\/strong>
\n
\nUpozor\u0148uje na to pacientsk\u00e1 organizace Onko Unie, kter\u00e1 se v\u011bnuje pot\u0159eb\u00e1m metastatick\u00fdch \u017een. Ve sv\u00e9 kampani \u201eNejsem na odpis!\u201c ji\u017e druh\u00fdm rokem informuje o probl\u00e9mech souvisej\u00edc\u00edch s p\u00e9\u010d\u00ed o tyto pacientky, v\u010detn\u011b p\u0159\u00edstupu k modern\u00ed l\u00e9\u010db\u011b.<\/p>\n

Odbornou garantkou kampan\u011b je docentka MUDr. Petra Tesa\u0159ov\u00e1, CSc., z Onkologick\u00e9 kliniky 1. LF UK a V\u0161eobecn\u00e9 fakultn\u00ed nemocnice v Praze, kter\u00e1 \u0159\u00edk\u00e1: \u201ePro pacientky s hormon\u00e1ln\u011b z\u00e1visl\u00fdm n\u00e1dorem je z\u00e1kladem l\u00e9\u010dby hormon\u00e1ln\u00ed terapie, d\u00edky kter\u00e9 m\u016f\u017eeme m\u00edt nemoc dlouhodob\u011b pod kontrolou. V p\u0159\u00edpad\u011b vzd\u00e1len\u00fdch metast\u00e1z se ale onkolog \u010dasto ob\u00e1v\u00e1 pomal\u00e9ho n\u00e1stupu \u00fa\u010dinku t\u00e9to l\u00e9\u010dby a vol\u00ed rad\u011bji chemoterapii. Ta v\u0161ak pro organizmus nemocn\u00e9 p\u0159edstavuje mnohem v\u011bt\u0161\u00ed z\u00e1t\u011b\u017e a v\u00edce ne\u017e\u00e1douc\u00edch \u00fa\u010dink\u016f. Dnes p\u0159ich\u00e1z\u00ed nov\u00e9 mo\u017enosti v podob\u011b c\u00edlen\u00e9 l\u00e9\u010dby. Tato l\u00e9\u010dba je dob\u0159e sn\u00e1\u0161en\u00e1, je pro pacienta bezpe\u010dn\u011bj\u0161\u00ed, a p\u0159itom m\u00e1 vysokou protin\u00e1dorovou \u00fa\u010dinnost.\u201c<\/p>\n

C\u00edlen\u00e1 l\u00e9\u010dba je ur\u010dena pro metastatick\u00e9 pacientky s hormon\u00e1ln\u011b z\u00e1visl\u00fdm n\u00e1dorem, to znamen\u00e1, \u017ee jeho r\u016fst z\u00e1vis\u00ed na p\u0159\u00edsunu \u017eensk\u00fdch hormon\u016f. Tento typ n\u00e1doru m\u00e1 zhruba \u0161edes\u00e1t procent \u017een s metastatickou rakovinou prsu. Nov\u00e1 l\u00e9\u010dba jim m\u016f\u017ee a\u017e dvojn\u00e1sobn\u011b prodlou\u017eit dobu do dal\u0161\u00edho postupu nemoci. \u201eJde o c\u00edlenou l\u00e9\u010dbu blokuj\u00edc\u00ed enzymy CDK 4\/6, kter\u00e9 zp\u016fsobuj\u00ed r\u016fst n\u00e1doru. Podle v\u00fdsledk\u016f klinick\u00fdch studi\u00ed m\u016f\u017ee tato l\u00e9\u010dba v pr\u016fm\u011bru z\u00e1sadn\u011b odd\u00e1lit dal\u0161\u00ed postup nemoci a prodlou\u017eit p\u0159e\u017eit\u00ed nemocn\u00fdch, a to p\u0159i velmi dobr\u00e9 kvalit\u011b \u017eivota, co\u017e je pro pacientky nesm\u00edrn\u011b d\u016fle\u017eit\u00e9,\u201c vysv\u011btluje docentka Tesa\u0159ov\u00e1.<\/p>\n

Za objev enzym\u016f CDK 4\/6 (cyklin dependentn\u00ed kin\u00e1zy), kter\u00e9 jsou zodpov\u011bdn\u00e9 za r\u016fst n\u00e1dorov\u00fdch bun\u011bk, z\u00edskala trojice v\u011bdc\u016f ze Spojen\u00fdch st\u00e1t\u016f americk\u00fdch a Velk\u00e9 Brit\u00e1nie v roce 2001 Nobelovu cenu.<\/p>\n

Nov\u00e1 c\u00edlen\u00e1 l\u00e9\u010dba pro hormon\u00e1ln\u011b z\u00e1visl\u00e9 pacientky je v \u0159ad\u011b evropsk\u00fdch zem\u00edch ji\u017e hrazena ze zdravotn\u00edho poji\u0161t\u011bn\u00ed a na cel\u00e9m sv\u011bt\u011b j\u00ed bylo l\u00e9\u010deno v\u00edce ne\u017e pades\u00e1t tis\u00edc pacientek. V \u010cesk\u00e9 republice zat\u00edm tato nov\u00e1 l\u00e9\u010dba nen\u00ed hrazena ze zdravotn\u00edho poji\u0161t\u011bn\u00ed a v sou\u010dasn\u00e9 dob\u011b prob\u00edh\u00e1 \u0159\u00edzen\u00ed o stanoven\u00ed ceny a \u00fahrady.<\/p>\n

\u0158editelka pacientsk\u00e9 organizace Onko Unie, Petra Ad\u00e1mkov\u00e1, k tomu \u0159\u00edk\u00e1: \u201ePacientky se u n\u00e1s k modern\u00edm l\u00e9k\u016fm obvykle dost\u00e1vaj\u00ed o dost pozd\u011bji ne\u017e v jin\u00fdch zem\u00edch Evropsk\u00e9 unie. Bohu\u017eel n\u011bkdy se pot\u0159eba modern\u00ed l\u00e9\u010dby pro \u017eeny v nevyl\u00e9\u010diteln\u00e9m stadiu nemoci dokonce zpochyb\u0148uje. To pro n\u011b ale m\u016f\u017ee b\u00fdt osudn\u00e9. A proto\u017ee samy pacientky \u010dasto nemaj\u00ed dostatek informac\u00ed, je na\u0161\u00ed rol\u00ed informovat je, h\u00e1jit jejich z\u00e1jmy a pomoci jim zajistit p\u0159\u00edstup k nejlep\u0161\u00ed mo\u017en\u00e9 terapii.\u201c<\/p>\n

Jako nejv\u011bt\u0161\u00ed p\u0159ek\u00e1\u017eka rychl\u00e9 a pln\u00e9 dostupnosti modern\u00ed l\u00e9\u010dby se zd\u00e1 b\u00fdt jej\u00ed finan\u010dn\u00ed n\u00e1ro\u010dnost. Faktem v\u0161ak je, \u017ee tato l\u00e9\u010dba se soust\u0159e\u010fuje do onkologick\u00fdch center, kter\u00e1 na ni dost\u00e1vaj\u00ed p\u0159edem ur\u010denou limitovanou \u010d\u00e1stku. Podle anal\u00fdzy spole\u010dnosti Oaks Consulting v roce 2015 zaplatily zdravotn\u00ed poji\u0161\u0165ovny za modern\u00ed l\u00e9ky v onkologick\u00fdch centrech necel\u00fdch 6 miliard korun, co\u017e jsou p\u0159ibli\u017en\u011b 2,2 procenta financ\u00ed z ve\u0159ejn\u00e9ho rozpo\u010dtu zdravotnictv\u00ed.<\/p>\n

V r\u00e1mci kulat\u00e9ho stolu k pot\u0159eb\u00e1m metastatick\u00fdch pacientek, kter\u00fd prob\u011bhl 28. \u010dervna 2017 pod z\u00e1\u0161titou Ministerstva zdravotnictv\u00ed \u010cesk\u00e9 republiky, o dostupnosti modern\u00ed l\u00e9\u010dby diskutovali tak\u00e9 z\u00e1stupci ministerstva, St\u00e1tn\u00edho \u00fastavu pro kontrolu l\u00e9\u010div a zdravotn\u00edch poji\u0161\u0165oven. Shodli se na tom, \u017ee jedn\u00edm z \u0159e\u0161en\u00ed je zajistit, aby \u00faspory z\u00edskan\u00e9 soustavn\u00fdm sni\u017eov\u00e1n\u00edm cen star\u0161\u00edch l\u00e9k\u016f byly pou\u017eity na hrazen\u00ed modern\u00edch l\u00e9\u010div. Jen za lo\u0148sk\u00fd rok tak d\u00edky \u00faspor\u00e1m na star\u0161\u00edch l\u00e9c\u00edch z\u00edskaly zdravotn\u00ed poji\u0161\u0165ovny prost\u0159edky ve v\u00fd\u0161i 4 miliardy korun.<\/p>\n

Kulat\u00fd st\u016fl p\u0159ipravily \u010dty\u0159i pacientsk\u00e9 organizace, kter\u00e9 se pot\u0159eb\u00e1m metastatick\u00fdch pacientek dlouhodob\u011b v\u011bnuj\u00ed. \u010clenem t\u00e9to platformy je tak\u00e9 Onko Unie. Letos v kv\u011btnu organizace podepsaly spole\u010dn\u00e9 Memorandum, kter\u00e9 shrnuje sedm hlavn\u00edch t\u00e9mat. Jedn\u00e1 se o dostupnost modern\u00ed l\u00e9\u010dby, ale tak\u00e9 zlep\u0161en\u00ed syst\u00e9mu soci\u00e1ln\u00ed podpory nebo pot\u0159eby psychologick\u00e9 pomoci pro nevyl\u00e9\u010diteln\u011b nemocn\u00e9 pacientky. V \u010cesku tak jde o prvn\u00ed podobn\u00e9 spojen\u00ed pacientsk\u00fdch organizac\u00ed s c\u00edlem pom\u00e1hat pacientk\u00e1m s metastatick\u00fdm onemocn\u011bn\u00edm prsu.<\/p>\n

O metastatick\u00e9 rakovin\u011b prsu<\/p>\n

Rakovina prsu je po rakovin\u011b k\u016f\u017ee druh\u00fdm nej\u010dast\u011bj\u0161\u00edm onkologick\u00fdm onemocn\u011bn\u00edm u \u017een. Ze statistik vypl\u00fdv\u00e1, \u017ee a\u017e t\u0159iceti procent\u016fm \u017een, kter\u00fdm byla diagnostikov\u00e1na rakovina prsu v ran\u00e9m stadiu a byly \u00fasp\u011b\u0161n\u011b l\u00e9\u010deny, se nemoc vr\u00e1t\u00ed, zpravidla u\u017e ve \u010dtvrt\u00e9m, metastatick\u00e9m, stadiu. V t\u00e9to f\u00e1zi se n\u00e1dor z prsu \u0161\u00ed\u0159\u00ed do dal\u0161\u00edch org\u00e1n\u016f t\u011bla, nej\u010dast\u011bji jsou metast\u00e1zami zasa\u017eeny j\u00e1tra, pl\u00edce, kosti a mozek. I v t\u00e9to nevyl\u00e9\u010diteln\u00e9 f\u00e1zi je ale metastatick\u00fd karcinom prsu dob\u0159e l\u00e9\u010diteln\u00fd a umo\u017e\u0148uje nemocn\u00fdm v\u00e9st plnohodnotn\u00fd kvalitn\u00ed \u017eivot.<\/p>\n

L\u00e9ka\u0159i dnes rozli\u0161uj\u00ed n\u011bkolik typ\u016f metastatick\u00e9 rakoviny prsu podle typu n\u00e1doru. Zhruba 60 procent pacientek m\u00e1 hormon\u00e1ln\u011b z\u00e1visl\u00fd n\u00e1dor. To znamen\u00e1, \u017ee r\u016fst n\u00e1doru z\u00e1vis\u00ed na p\u0159\u00edsunu \u017eensk\u00fdch hormon\u016f estrogenu a progesteronu. B\u00fdv\u00e1 tak\u00e9 naz\u00fdv\u00e1n jako hormon pozitivn\u00ed nebo HR-pozitivn\u00ed karcinom.<\/p>\n

Jana B\u011bhalov\u00e1
\nTiskov\u00e1 zpr\u00e1va<\/p>\n","protected":false},"excerpt":{"rendered":"

Ka\u017edodenn\u00ed boj o \u010das. To je \u00fad\u011bl pacientek s metastatick\u00fdm karcinomem prsu. Tedy s nejpokro\u010dilej\u0161\u00edm stadiem rakoviny. V sou\u010dasn\u00e9 dob\u011b je v \u010cesk\u00e9 republice zhruba […]<\/a><\/p>\n<\/div>","protected":false},"author":1,"featured_media":7884,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,9],"tags":[],"class_list":["post-28890","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-zdravi","category-zpravy"],"_links":{"self":[{"href":"https:\/\/www.invarena.cz\/index.php?rest_route=\/wp\/v2\/posts\/28890","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.invarena.cz\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.invarena.cz\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.invarena.cz\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.invarena.cz\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=28890"}],"version-history":[{"count":0,"href":"https:\/\/www.invarena.cz\/index.php?rest_route=\/wp\/v2\/posts\/28890\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.invarena.cz\/index.php?rest_route=\/wp\/v2\/media\/7884"}],"wp:attachment":[{"href":"https:\/\/www.invarena.cz\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=28890"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.invarena.cz\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=28890"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.invarena.cz\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=28890"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}